# Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell

> **NCT02916316** · — · COMPLETED · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 127 (actual)

## Conditions studied

- Lymphoma
- Large B-Cell
- Diffuse Large B-Cell

## Interventions

- **DRUG:** R-CHOP with doxorubicin

## Key facts

- **NCT ID:** NCT02916316
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-12
- **Primary completion:** 2020-12-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02916316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02916316, "Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02916316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*